These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20592377)

  • 21. VEGF and IL-18 in induced sputum of lung cancer patients.
    Rovina N; Hillas G; Dima E; Vlastos F; Loukides S; Veldekis D; Roussos C; Alhanatis M; Bakakos P
    Cytokine; 2011 Jun; 54(3):277-81. PubMed ID: 21398142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B; Heching N; Biran H; Barak V; Peretz T
    Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y; Wang Y; Li J; Hao X; Hu X
    Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
    Huang Z; Xu D; Zhang F; Ying Y; Song L
    Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival.
    Crohns M; Saarelainen S; Laine S; Poussa T; Alho H; Kellokumpu-Lehtinen P
    Cytokine; 2010 Apr; 50(1):30-6. PubMed ID: 20044268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.
    Petrović M; Bukumirić Z; Zdravković V; Mitrović S; Atkinson HD; Jurišić V
    Med Oncol; 2014 Feb; 31(2):823. PubMed ID: 24375395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J; Li R; Li A
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor (VEGF) serum levels are associated with survival in early stages of lung cancer patients.
    Carrillo-de Santa Pau E; Carrillo Arias F; Caso Pelaez E; Muguruza Trueba I; Sánchez Hernández I; Muñoz Molina GM; Moreno Balsalobre R; Sacristán López S; Gómez-Pinillos A; Toledo Lobo Mdel V
    Cancer Invest; 2010 May; 28(4):393-8. PubMed ID: 19968501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical value of vascular endothelial growth factor in patients with small cell lung cancer].
    Liu J; Zhu X
    Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):406-10. PubMed ID: 21126410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
    Jin B; Zhao L; Zhou C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
    Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognostic factors in patients with small cell lung cancer].
    Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].
    Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T
    Pol Merkur Lekarski; 2007 Jun; 22(132):536-8. PubMed ID: 17874624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
    Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
    Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
    Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
    Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.